Target intelligence / Profile preview

Actin and other accessible protein thiols

Molecular classification
Cytoskeletal protein, Other
01

Overview

Actin and other accessible protein thiols represent a heterogeneous group of molecular targets defined by the presence of reactive cysteine sulfhydryl (-SH) groups. Actin is a primary component of this group because its Cys374 residue is highly nucleophilic and solvent-accessible, making it a frequent site for covalent modification by electrophilic compounds (Biochemistry, 1990). These thiol groups are essential for maintaining protein structure, regulating enzymatic activity, and facilitating redox-sensitive signaling pathways (Nature Reviews Molecular Cell Biology). Drugs such as the loop diuretic ethacrynic acid interact with these targets by acting as electrophilic Michael acceptors, forming stable covalent adducts with the sulfhydryl groups (DrugBank). This interaction leads to the disruption of the actin cytoskeleton and the inhibition of various thiol-dependent enzymes, such as glutathione S-transferase, which can result in cellular morphological changes like blebbing (Journal of Pharmacology and Experimental Therapeutics). While this mechanism is utilized for therapeutic effects in managing edema and exploring cancer sensitization, the inherent lack of specificity for a single protein poses significant safety concerns, including ototoxicity and systemic oxidative stress (StatPearls).

Other names
Protein sulfhydrylsReactive protein thiolsCysteine sulfhydryl groupsProtein-bound thiolsReactive cysteine residues
02

Mechanism of action

Covalent modification of sulfhydryl (-SH) groups on cysteine residues via Michael addition or oxidation, leading to protein dysfunction, enzymatic inhibition, and cytoskeletal disruption.

03

Biological functions

Cytoskeletal organizationRedox homeostasisEnzymatic regulationSignal transductionCellular detoxification
04

Disease associations

EdemaCancerOxidative stress-related disordersInflammation
05

Safety considerations

OtotoxicityNon-specific covalent binding to off-target proteinsDepletion of cellular antioxidantsNephrotoxicityGastrointestinal irritation
06

Interacting drugs

Ethacrynic acid

4 more in the full profile.

07

Biomarkers

Glutathione (GSH) levelsProtein-thiol adductsTotal antioxidant capacityCellular redox potential (GSH/GSSG ratio)

Beyond the preview

Go deeper on Actin and other accessible protein thiols.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin and other accessible protein thiols.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call